{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T21:09:07Z","timestamp":1766869747458,"version":"3.37.3"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T00:00:00Z","timestamp":1187308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,23]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>It has been shown previously that sera from patients with cholestatic liver diseases react with sulphite oxidase (SO) prepared from chicken liver. In order to analyse this reactivity and the clinical relevance of anti-SO antibodies in more detail, we produced human recombinant SO. Human recombinant SO (60\u2003kDa) was expressed in Escherichia coli and applied to enzyme-linked immunosorbent assay and Western blot. Sera from patients with autoimmune liver disorders [primary biliary cirrhosis (PBC) n\u2003=\u200396; autoimmune hepatitis (AIH) n\u2003=\u200377; primary sclerosing cholangitis (PSC) n\u2003=\u200339], and from patients with other hepatic (n\u2003=\u2003154) and non-hepatic chronic inflammatory disorders (n\u2003=\u2003113) were investigated. Highest incidence and activities of IgG-anti-SO antibodies were observed in PSC patients. Nine of 16 untreated (56%) and four of 23 PSC patients treated with ursodeoxycholic acid (UDCA) (17%) were positive. Antibody activity decreased significantly during UDCA treatment. Five per cent of PBC and 9% of AIH patients, but also 15% of patients with alcoholic liver disease, were IgG anti-SO-positive. In patients with viral hepatitis and non-hepatic disorders they could be hardly detected. Anti-SO antibodies are further anti-mitochondrial antibodies in chronic liver diseases. They occur predominantly in PSC, and UDCA treatment seams to decrease antibody activity. Whether these antibodies are primary or secondary phenomena and whether they are related to the aetiology or pathogenesis, at least in a subgroup of patients with chronic liver diseases, has still to be evaluated.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2007.03482.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T14:09:15Z","timestamp":1281622155000},"page":"312-321","source":"Crossref","is-referenced-by-count":12,"title":["Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance"],"prefix":"10.1093","volume":"150","author":[{"given":"B","family":"Preu\u00df","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, University of Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Berg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University of Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Altenberend","sequence":"additional","affiliation":[{"name":"Interfacultary Institute for Cellular Immunology, University of Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Gregor","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University of Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Stevanovic","sequence":"additional","affiliation":[{"name":"Interfacultary Institute for Cellular Immunology, University of Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, University of Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,8,17]]},"reference":[{"key":"2022010406284521300_b1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000171347","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance","volume":"10","author":"Berg","year":"1992","journal-title":"Dig Dis Sci"},{"key":"2022010406284521300_b2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0676.1995.tb00687.x","article-title":"Mitochondrial antigen\/antibody systems in primary biliary cirrhosis: revisited","volume":"15","author":"Berg","year":"1995","journal-title":"Liver"},{"key":"2022010406284521300_b3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(82)91327-7","article-title":"ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis","volume":"ii","author":"Berg","year":"1982","journal-title":"Lancet"},{"key":"2022010406284521300_b4","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70kD mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol"},{"key":"2022010406284521300_b5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(88)91894-6","article-title":"Identification of two major M2 mitochondrial antigens","volume":"i","author":"Yeaman","year":"1988","journal-title":"Lancet"},{"key":"2022010406284521300_b6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.1840060402","article-title":"Characterization and clinical relevance of a new complement fixing antibody\u2003\u2212\u2003anti-M8\u2003\u2212\u2003in patients with primary biliary cirrhosis","volume":"6","author":"Weber","year":"1986","journal-title":"Hepatology"},{"key":"2022010406284521300_b7","first-page":"445","article-title":"Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space","volume":"84","author":"Klein","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2022010406284521300_b8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2249.1995.tb06646.x","article-title":"Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies","volume":"102","author":"Bunn","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2022010406284521300_b9","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hep.1840160505","article-title":"M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?","volume":"16","author":"Davis","year":"1992","journal-title":"Hepatology"},{"key":"2022010406284521300_b10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0168-8278(05)80253-3","article-title":"M4 and M9 autoantigens in primary biliary cirrhosis\u2003\u2212\u2003a negative study","volume":"18","author":"Palmer","year":"1993","journal-title":"J Hepatol"},{"key":"2022010406284521300_b11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)80488-2","article-title":"Molecular basis of sulfite oxidase deficiency from the structure of sulfite oxidase","volume":"91","author":"Kisker","year":"1997","journal-title":"Cell"},{"key":"2022010406284521300_b12","first-page":"423","article-title":"Sulfite oxidase\u2003\u2212\u2003a new antigen system in cryptogenic liver disorders?","volume":"210","author":"Preu\u00df","year":"2005","journal-title":"Immunobiology"},{"issue":"4","key":"2022010406284521300_b13","first-page":"263A","article-title":"The mitochondrial enzyme sulfite oxidase\u2003\u2212\u2003a new antigen\/antibody system in primary sclerosing cholangitis (PSC): specificity and clinical implications","volume":"44","author":"Preu\u00df","year":"2006","journal-title":"Hepatology"},{"key":"2022010406284521300_b14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"2022010406284521300_b15","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability-based protein identification by searching sequence databases using mass spectrometry data","volume":"20","author":"Perkins","year":"1999","journal-title":"Electrophoresis"},{"key":"2022010406284521300_b16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","article-title":"Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels","volume":"68","author":"Shevchenko","year":"1996","journal-title":"Anal Chem"},{"key":"2022010406284521300_b17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.126.2.277","article-title":"Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes","volume":"126","author":"Berg","year":"1967","journal-title":"J Exp Med"},{"key":"2022010406284521300_b18","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.1840140632","article-title":"Significance and specificity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis","volume":"14","author":"Klein","year":"1991","journal-title":"Hepatology"},{"key":"2022010406284521300_b19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.1840050510","article-title":"Mitochondrial antibodies in primary biliary cirrhosis. Further characterization of the M2-antigen by immunoblotting, revealing species and non-species specific determinants","volume":"5","author":"Lindenborn-Fotinos","year":"1985","journal-title":"Hepatology"},{"key":"2022010406284521300_b20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0676.1997.tb00793.x","article-title":"Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years","volume":"17","author":"Klein","year":"1997","journal-title":"Liver"},{"key":"2022010406284521300_b21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"2022010406284521300_b22","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010406284521300_b23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/CRIAI:28:2:115","article-title":"Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases","volume":"28","author":"Terjung","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"2022010406284521300_b24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","article-title":"Overlap syndromes","volume":"25","author":"Beuers","year":"2005","journal-title":"Semin Liver Dis"},{"key":"2022010406284521300_b25","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2022010406284521300_b26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00042737-200406000-00012","article-title":"Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease","volume":"16","author":"Gheorghe","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022010406284521300_b27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"Van Buuren","year":"2000","journal-title":"J Hepatol"},{"key":"2022010406284521300_b28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00042737-200510000-00011","article-title":"Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective","volume":"17","author":"Kingham","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022010406284521300_b29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0168-8278(96)80144-9","article-title":"Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titer, specificity and IgG subclass","volume":"24","author":"Bansi","year":"1996","journal-title":"J Hepatol"},{"key":"2022010406284521300_b30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0676.1996.tb00700.x","article-title":"Antineutrophil cytoplasmic antibodies in autoimmune liver and inflammatory bowel diseases","volume":"16","author":"Claise","year":"1996","journal-title":"Liver"},{"key":"2022010406284521300_b31","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/0016-5085(91)70028-V","article-title":"Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis","volume":"100","author":"Duerr","year":"1991","journal-title":"Gastroenterology"},{"key":"2022010406284521300_b32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcp\/99.3.277","article-title":"Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases","volume":"99","author":"Hardarson","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"2022010406284521300_b33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"2022010406284521300_b34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/gut.33.5.657","article-title":"Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis","volume":"33","author":"Seibold","year":"1992","journal-title":"Gut"},{"key":"2022010406284521300_b35","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0016-5085(95)90215-5","article-title":"High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis","volume":"108","author":"Targan","year":"1995","journal-title":"Gastroenterology"},{"key":"2022010406284521300_b36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","article-title":"Anti-neutrophil cytoplasmic antibodies in type 1 and type 2 autoimmune hepatitis","volume":"25","author":"Zauli","year":"1997","journal-title":"Hepatology"},{"key":"2022010406284521300_b37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0270-9139(93)90042-L","article-title":"Investigation of the specific autoantigen of primary sclerosing cholangitis by Western blot and immunoprecipitation","volume":"18","author":"Berg","year":"1993","journal-title":"Hepatology"},{"key":"2022010406284521300_b38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/hep.1840180241","article-title":"Investigation of the specific autoantigen of primary sclerosing cholangitis by Western blot and immunoprecipitation","volume":"18","author":"Lo","year":"1993","journal-title":"Hepatology"},{"key":"2022010406284521300_b39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanism of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"2022010406284521300_b40","first-page":"1123","article-title":"Prevalence, kinetics and therapeutic modulation of autoantibodies against sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis","volume":"26","author":"Zuchner","year":"1997","journal-title":"Hepatology"},{"key":"2022010406284521300_b41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj1110297","article-title":"The cryptic nature of hepatic microsomal sulphite oxidase","volume":"111","author":"Joshi","year":"1969","journal-title":"Biochem J"},{"key":"2022010406284521300_b42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.147.4.809","article-title":"The pro-apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol","volume":"147","author":"Kluck","year":"1999","journal-title":"J Cell Biol"},{"key":"2022010406284521300_b43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.cdd.4400640","article-title":"Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition","volume":"7","author":"Patterson","year":"2000","journal-title":"Cell Death Differ"},{"key":"2022010406284521300_b44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00042737-200502000-00001","article-title":"Immunomodulating and anti-apoptotic action of ursodeoxycholic acid: where are we and where should we go?","volume":"17","author":"Bellentani","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022010406284521300_b45","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.1021\/bi050621a","article-title":"Characterization of an Escherichia coli sulfite oxidase homologue reveals the role of a conserved active site cysteine in assembly and function","volume":"44","author":"Brokx","year":"2005","journal-title":"Biochemistry"},{"key":"2022010406284521300_b46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.arplant.50.1.277","article-title":"Nitrate reductase structure, function and regulation: bridging the gap between biochemistry and physiology","volume":"50","author":"Campbell","year":"1999","journal-title":"Annu Rev Plant Physiol Plant Mol Biol"},{"key":"2022010406284521300_b47","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.str.2003.09.007","article-title":"Plants have SOX: the structure of sulfite oxidase from Aradopsis thaliana","volume":"11","author":"Hille","year":"2003","journal-title":"Structure"},{"key":"2022010406284521300_b48","first-page":"127","article-title":"IgG2 subclass restriction of antibody to pneumococcal polysaccharides","volume":"63","author":"Barrett","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"2022010406284521300_b49","first-page":"29","article-title":"IgG subclasses of human autoantibodies","volume":"148","author":"Maran","year":"1997","journal-title":"Ann Med (Paris)"},{"key":"2022010406284521300_b50","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.1780401112","article-title":"Anticardiolipin IgG subclasses: association of IgG2 with arterial and\/or venous thrombosis","volume":"40","author":"Sammaritano","year":"1997","journal-title":"Arthritis Rheum"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2007.03482.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/150\/2\/312\/42038177\/j.1365-2249.2007.03482.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/150\/2\/312\/42038177\/j.1365-2249.2007.03482.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:09:40Z","timestamp":1740380980000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/150\/2\/312\/6457686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,17]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,8,17]]},"published-print":{"date-parts":[[2007,8,23]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03482.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"type":"print","value":"0009-9104"},{"type":"electronic","value":"1365-2249"}],"subject":[],"published-other":{"date-parts":[[2007,11]]},"published":{"date-parts":[[2007,8,17]]}}}